1. Home
  2. BCAB vs LITB Comparison

BCAB vs LITB Comparison

Compare BCAB & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • LITB
  • Stock Information
  • Founded
  • BCAB 2007
  • LITB 2007
  • Country
  • BCAB United States
  • LITB Singapore
  • Employees
  • BCAB N/A
  • LITB N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • LITB Catalog/Specialty Distribution
  • Sector
  • BCAB Health Care
  • LITB Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • LITB Nasdaq
  • Market Cap
  • BCAB 40.5M
  • LITB 36.4M
  • IPO Year
  • BCAB 2020
  • LITB N/A
  • Fundamental
  • Price
  • BCAB $0.78
  • LITB $2.31
  • Analyst Decision
  • BCAB Hold
  • LITB
  • Analyst Count
  • BCAB 3
  • LITB 0
  • Target Price
  • BCAB $1.00
  • LITB N/A
  • AVG Volume (30 Days)
  • BCAB 1.2M
  • LITB 28.9K
  • Earning Date
  • BCAB 11-13-2025
  • LITB 11-12-2025
  • Dividend Yield
  • BCAB N/A
  • LITB N/A
  • EPS Growth
  • BCAB N/A
  • LITB N/A
  • EPS
  • BCAB N/A
  • LITB 0.24
  • Revenue
  • BCAB N/A
  • LITB $219,105,000.00
  • Revenue This Year
  • BCAB N/A
  • LITB N/A
  • Revenue Next Year
  • BCAB N/A
  • LITB N/A
  • P/E Ratio
  • BCAB N/A
  • LITB $8.46
  • Revenue Growth
  • BCAB N/A
  • LITB N/A
  • 52 Week Low
  • BCAB $0.24
  • LITB $0.91
  • 52 Week High
  • BCAB $2.05
  • LITB $4.17
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 55.58
  • LITB 36.90
  • Support Level
  • BCAB $0.62
  • LITB $2.73
  • Resistance Level
  • BCAB $0.73
  • LITB $3.15
  • Average True Range (ATR)
  • BCAB 0.09
  • LITB 0.37
  • MACD
  • BCAB 0.00
  • LITB -0.16
  • Stochastic Oscillator
  • BCAB 47.44
  • LITB 2.86

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: